# Galectin Therapeutics Inc: Form 8-K, filed Jan 21, 2026

- Company: [Galectin Therapeutics Inc](/companies/galt.md) (CIK 1133416)
- Form: 8-K
- Filed: 2026-01-21
- Accepted by EDGAR: Jan 21, 2026, 22:01 ET
- Period: 2026-01-16
- Accession: 0001140361-26-001866
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1133416/000114036126001866/ef20063365_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1133416/000114036126001866/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1133416/000114036126001866/ef20063365_8k.htm

Filed Jan 21, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-001866. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.
